Lv46
646 积分 2025-01-05 加入
晚期肝恶性肿瘤患者接受经桡和经股入路肝动脉灌注化疗的患者体验及入路相关并发症分析
12天前
已完结
对不可进行病灶切除术的结直肠癌肝转移患者实施肝动脉持续灌注化疗的效果
12天前
已关闭
初始不可切除结直肠癌肝转移转化治疗结局影响因素分析
12天前
已完结
[Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection]
12天前
已关闭
Prophylactic Adjuvant Hepatic Arterial Infusion Chemotherapy Reduced Hepatic Metastases from Stage III Colorectal Cancer after Curative Resection
12天前
已完结
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)
12天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
16天前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
27天前
已完结
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1个月前
已完结
O2-1 Nivolumab + ipilimumab versus chemotherapy in MSI-H/dMMR metastatic colorectal cancer: CheckMate 8HW Asian subgroup analysis
1个月前
已关闭
皖公网安备34019202002308
